Stock screenerAll disclosures → EDGAR →
LENZ
Conviction 18HealthcareScan · Thu, Jun 25, 2026Hammer
LENZ$5.50-1.43%
ResistanceSupportVol 14Vol MA14 671.34K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price5.50
Change-1.43%
Gap+0.63%
Rel volume1.91×
Avg volume681K
Avg $ vol4.47M
SMA 206.66
SMA 507.94
SMA 20019.36
Price vs 50-30.69%
Price vs 200-71.59%
MA stackbearish
50/200 cross—
Supertrenddown · 6.87
RSI (14)25
MACD hist-0.05
MACD crossbear · 4d
Stoch %K / %D13 / 5
ADX (14)25
+DI / −DI15 / 31
RSI divergenceBullish
MACD divergenceBullish
ATR %+9.13%
ADR %6.78%
52w high49.05
52w low5.50
From 52w high-88.79%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width40.02%
%B0.06
Donchian pos8.56%
Donchian high8.49
Donchian low5.22
AVWAP (52w high)18.40
vs AVWAP high-70.11%
AVWAP (52w low)5.46
vs AVWAP low+0.70%
OBV trendDown
Chaikin MF (20)-0.39
Today vs 20d1.91×
Avg vol (14d)671.34K
Avg vol (20d)681K
Avg $ vol (20d)4.47M
Market cap172.45M
RS 3m (vs SPY)-50.46%
RS 6m (vs SPY)-76.74%
RS line new highNo
Trend template0/8
Technical rank3.5
1 week-13.25%
1 month-29.03%
3 months-39.36%
6 months-68.79%
1 year-81.53%
YTD-65.62%
P/E-2.10
P/B0.70
P/S9.03
P/FCF-2.46
EPS-2.85
Div yield—
ROE-33.32%
ROA-30.13%
Debt/Eq—
Current10.40
EV/EBITDA-1.63
Gross margin—
Net margin-430.25%
Rev growth—
EPS growth-65.02%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value147.68M
Revenue1.9M
Net income-41.49M
Gross profit—
Free cash flow-70M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out31.35M
Employees152
ListedFri, Mar 22, 2024
Free float18.26M
Float %58.3%
Short interest10.23M
Days to cover12.6d
Short volume75.7%
Squeeze score99 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast−$1.21 · 4 est
Last EPS vs est−$1.32 vs −$1.10
Last surprise-20.0% miss
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank3.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LENZ
No recent disclosed trades by Congress in LENZ. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LENZ
No recent insider (Form 4) filings in LENZ. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in LENZ · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.